Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03965741

Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners — PRACTISE  

Venous Thromboembolism (VTE) Clinical Trial

Official title:
Prostate Cancer VTE in Sweden: Epidemiology and Anticoagulation Treatment of VTE

Clinical Trial Summary

Patients with cancer are at a significantly increased risk of experiencing a venous thromboembolism (VTE). VTE is defined by a blood clot in the leg or lower extremity (deep vein thrombosis) or a blood clot in the lung (pulmonary embolism) and is a leading cause of condition of being diseased and death among cancer patients. The goal of the study is to gather information how often venous thromboembolism (VTE) occurs in prostate cancer patients in Sweden and how this condition is treated with blood thinners.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03965741
Study type Observational
Source Bayer
Contact
Status Completed
Phase
Start date May 30, 2019
Completion date November 30, 2020
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03265054 - Evaluation of the Predictive Value of the Microvesicle Coagulo-lytic Balance in the Recurrence of Venous Thrombosis N/A
Completed NCT04141228 - A Study of Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Treated With Apixaban or Warfarin in the US
Completed NCT01119274 - EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon Phase 4
Completed NCT02798471 - Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) Phase 3
Completed NCT01583218 - Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) Phase 3
Completed NCT03521908 - A Study to Compare the Risk of a Major Bleeding in Participants Who Received Blood Thinning Medications Following a Blood Clot
Recruiting NCT03802929 - Diagnostic and Prognostic Prediction Models for Chinese Patients With Venous Thromboembolism
Completed NCT02073682 - Cancer Venous Thromboembolism (VTE) Phase 3
Completed NCT03977870 - Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome Analysis
Recruiting NCT06057844 - Molecular Imaging of Active Venous Thrombus With Positron Emission Tomography (PET) N/A
Completed NCT04243122 - Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients Phase 2
Active, not recruiting NCT06443905 - Xueshuantong Injection (Lyophilized) in the Prevention of Venous Thromboembolism (VTE) in Hospitalized Patients
Recruiting NCT02156401 - VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE